TGFB1 and cancer: Huang et al. developed a TGF-β siRNA-containing nanoformulation that synergized with cancer vaccination, which achieved silence of TGF-β expression, to significantly enhance its therapeutic effect on advanced tumors (Xu et al., 2014).